Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
Department of Microbiology, College of Science, Oregon State University, Corvallis, OR 97331, USA.
J Med Microbiol. 2011 Dec;60(Pt 12):1734-1741. doi: 10.1099/jmm.0.031575-0. Epub 2011 Jul 28.
Clostridium perfringens type A is the causative agent of a variety of histotoxic and enteric diseases. The ability of C. perfringens spores to germinate in vivo might be due to the presence of nutrient germinants in the host tissue and blood. In the current study, we investigated the ability of spores of C. perfringens wild-type and mutation strains to germinate in blood. Results indicate that spores of all three surveyed C. perfringens wild-type isolates germinated better in blood than in brain heart infusion (BHI) broth. However, as expected, spores lacking germinant receptor (GR) protein GerAA or GerKB germinated like wild-type spores in BHI broth and blood. Strikingly, while spores lacking GR proteins GerKA and GerKC showed significantly decreased germination in BHI broth, these spores germinated well in blood, suggesting that blood factor(s) can trigger spore germination through a GR-independent pathway. Using C. perfringens spores lacking cortex lytic enzymes (ΔcspB or ΔsleC ΔsleM), we were able to identify a host serum germination factor with peptidoglycan hydrolysing activity that (i) restored the colony-forming efficiencies of ΔcspB and ΔsleC ΔsleM spores up to ~5-20% of that of total colony-forming spores; (ii) increased the number of c.f.u. of decoated ΔcspB and ΔsleC ΔsleM spores to ~99% of that of colony-forming spores; (iii) and finally lost enzymic activity after heat inactivation, consistent with serum germination factor being an enzyme. Further characterization demonstrated that serum germination factor is very likely lysozyme, which can form a stable high molecular mass complex of ~120 kDa in serum. In conclusion, the current study indicates that a host serum germination factor with peptidoglycan hydrolysing activity is capable of triggering germination of C. perfringens spores by directly degrading the spore peptidoglycan cortex. Collectively, this study contributes to our understanding of the mechanism of in vivo germination of spores of C. perfringens.
A 型产气荚膜梭菌是多种组织毒性和肠道疾病的病原体。产气荚膜梭菌孢子在体内萌发的能力可能是由于宿主组织和血液中存在营养萌发剂。在本研究中,我们研究了 C. perfringens 野生型和突变菌株的孢子在血液中的萌发能力。结果表明,所有三种调查的 C. perfringens 野生型分离株的孢子在血液中的萌发能力均优于脑心浸液 (BHI) 肉汤。然而,正如预期的那样,缺乏萌发受体 (GR) 蛋白 GerAA 或 GerKB 的孢子在 BHI 肉汤和血液中与野生型孢子的萌发情况相同。引人注目的是,虽然缺乏 GR 蛋白 GerKA 和 GerKC 的孢子在 BHI 肉汤中的萌发率显著降低,但这些孢子在血液中萌发良好,表明血液因子可以通过非 GR 途径触发孢子萌发。使用缺乏皮质裂解酶的 C. perfringens 孢子 (ΔcspB 或 ΔsleC ΔsleM),我们能够鉴定出一种具有肽聚糖水解活性的宿主血清萌发因子,该因子 (i) 将 ΔcspB 和 ΔsleC ΔsleM 孢子的集落形成效率恢复至总集落形成孢子的 5-20%左右;(ii) 将脱壳的 ΔcspB 和 ΔsleC ΔsleM 孢子的 c.f.u.数量增加至集落形成孢子的 99%左右;(iii) 最后在热失活后失去酶活性,这与血清萌发因子是一种酶一致。进一步的表征表明,血清萌发因子很可能是溶菌酶,它可以在血清中形成一个稳定的高分子量复合物,分子量约为 120 kDa。总之,本研究表明,具有肽聚糖水解活性的宿主血清萌发因子能够通过直接降解孢子的肽聚糖皮质来触发产气荚膜梭菌孢子的萌发。总的来说,这项研究有助于我们理解产气荚膜梭菌孢子在体内萌发的机制。